Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 Diabetes
- 1 May 2003
- journal article
- review article
- Published by American Diabetes Association in Diabetes
- Vol. 52 (5) , 1059-1065
- https://doi.org/10.2337/diabetes.52.5.1059
Abstract
No abstract availableThis publication has 123 references indexed in Scilit:
- Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes.Diabetes Care, 2000
- Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study.Diabetes Care, 1999
- Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users StudyDiabetes, 1996
- Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDMDiabetes, 1996
- HLA antigens and age at diagnosis of insulin-dependent diabetes mellitusHuman Immunology, 1995
- A Randomized Trial of Intensive Insulin Therapy in Newly Diagnosed Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1989
- Immunosuppression with Azathioprine and Prednisone in Recent-Onset Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988
- Residual C‐Peptide Production in Type I Diabetes Mellitus: A Comparison of Different Methods of Assessment and Influence on Glucose ControlActa Medica Scandinavica, 1983
- Carbimazole and the Autoimmune Response in Graves' DiseaseNew England Journal of Medicine, 1980
- C-Peptide response to arginine stimulation in diabetic childrenThe Journal of Pediatrics, 1980